In the final installment of The Pandemic Puzzle: Lessons from COVID-19, leaders in government, academia, health care and business said biomedical and digital health advances of the last few years will help combat future health crises.

Efforts to design a hepatitis C vaccine, understand the genetic causes of rare diseases, map genetic regulatory elements in organ systems and understand coronavirus immune responses garner over $40 million.

Five Stanford researchers will participate in a $180 million nationwide campaign by the National Institutes of Health to understand the effect of human-genome variations on health and disease.

The director of the Center for Innovation in Global Health explains how the medical community is at the center of the climate change debate.

Stanford researchers have developed a synthetic, tumor-targeting molecule that promotes immune activation and tumor regression in laboratory mice after it’s injected into their bloodstreams.

A potential COVID-19 vaccine, delivered via a squirt up the nose, shows promise in mice.

Kelsey was known for her teaching skills, her expertise in musculoskeletal disorders and her love of golden retrievers.

Psychiatrist Lawrence Fung expanded his autism research into developing a program that helps those on the spectrum find jobs.

Bateman, a Harvard faculty member and prominent health care leader, brings his expertise as a researcher in maternal health and faculty development to Stanford.

Basketball players who weave through defense to shoot the basket face a higher risk of tears in the anterior cruciate ligament (ACL), but after repair return to the same level of play.